title: Bethanechol for buprenorphine-related urinary hesitancy: a case series.
abstract: Constipation is a well-known side effect of buprenorphine, but urinary hesitancy is less frequently discussed and may go unrecognized. Reported are the 2 cases of men older than 50 years who experienced disabling urinary hesitancy with buprenorphine and naloxone combination (suboxone) and were successfully treated with bethanechol, a cholinergic medication.
authors.affiliation: Department of Psychiatry, Veteran's Affairs Medical Centre, Salem, VA, USA. anjali.varma@va.gov
authors.forename: Anjali
authors.initials: A
authors.lastname: Varma
authors.forename: Joseph
authors.initials: J
authors.lastname: Smigiel
authors.forename: Nancy
authors.initials: N
authors.lastname: Eck
authors.forename: Stephanie
authors.initials: S
authors.lastname: Brooks
mesh_terms: D018723:Bethanechol / Q000627:therapeutic use*; D002047:Buprenorphine / Q000008:administration & dosage / Q000009:adverse effects*; D000069479:Buprenorphine, Naloxone Drug Combination; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008875:Middle Aged; D018721:Muscarinic Agonists / Q000627:therapeutic use*; D009270:Naloxone / Q000008:administration & dosage; D009294:Narcotics / Q000009:adverse effects*; D016896:Treatment Outcome; D014555:Urination Disorders / Q000139:chemically induced* / Q000188:drug therapy*
chemical_list: D000069479:Buprenorphine, Naloxone Drug Combination; D004338:Drug Combinations; D018721:Muscarinic Agonists; D009294:Narcotics; D018723:Bethanechol; D009270:Naloxone; D002047:Buprenorphine